Panos Konstantinopoulos, MD, PhD shares results of a phase 2 endometrial cancer study at 2022 SGO.

Panos Konstantinopoulos, MD, PhD shares results of a phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer at the 2022 Society for Gynecologic Oncology Annual Meeting.

• فئة